Moleculin Biotech, Inc. (MBRX) — Dilution Risk Analysis

Current Snapshot

Moleculin Biotech, Inc. (MBRX) has a DilutionWatch score of 92/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
19,477,380 Source
Public Float
5,292,005 Source
Float as % of Outstanding
27.2%

Dilution Risk Score

Score: 92/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 8-K 2, 4 3, 424B3 1, EFFECT 1, XBRL 2.

FormFiledAccession
8-K 2026-06-30 0001437749-26-022087
4 2026-06-24 0001437749-26-021610
4 2026-06-24 0001437749-26-021611
4 2026-06-24 0001437749-26-021612
8-K 2026-04-15 0001437749-26-012325
424B3 2026-04-14 0001437749-26-012262
EFFECT 2026-04-14 9999999995-26-001181
xbrl 2025-12-31 xbrl-7005-xbrl_warrant
xbrl 2018-12-31 xbrl-7005-xbrl_convertible

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $15,300,000 Source
Cash runway 3 months Source
Three-year share count growth 7740.49% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 92/10) Source
Cash Runway
3 months Source
ATM Offering Capacity Remaining
$15,300,000 Source
Share Count Growth (3-Year)
7740.49% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.